Liposomal Bupivacaine Use in Alveolar Bone Graft Patients
The goal of this clinical trial is to learn if a pain medication called liposomal bupivacaine (brand name EXPAREL®) with epinephrine will provide better pain control, increased activity, and reduced use of opioids compared with the standard treatment for patients age 6 years and older with cleft lip and palate who have had an alveolar bone graft surgery. Investigators will look at:

pain scores at hip and jaw sites
opioid use in amount and frequency
scores on activity questionnaires Researchers will compare the results of these items with those of patients who had the standard treatment of bupivacaine with epinephrine.
- EligibilityCriteria: Inclusion Criteria:  Patients that are 6 and older who have a diagnosis of cleft lip and/or palate with a scheduled surgery that involves an alveolar bone graft.  Exclusion Criteria:  Patients under age 6 are excluded from this study as EXPAREL® is not FDA approved for this group. - HealthyVolunteers: No - Gender: All - MinimumAge: 6 Years - StdAgeList: Child, Adult, Older Adult